000 | 01290 a2200433 4500 | ||
---|---|---|---|
005 | 20250516161815.0 | ||
264 | 0 | _c20130816 | |
008 | 201308s 0 0 eng d | ||
022 | _a0031-7144 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiao, Yun | |
245 | 0 | 0 |
_aDevelopment and validation of a risk score for predicting invasive fungal infectious in an intensive care unit. _h[electronic resource] |
260 |
_bDie Pharmazie _cJun 2013 |
||
300 |
_a459-64 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Validation Study | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aCross Infection _xdiagnosis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHospital Mortality |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntensive Care Units |
650 | 0 | 4 | _aLength of Stay |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aModels, Statistical |
650 | 0 | 4 |
_aMycoses _xdiagnosis |
650 | 0 | 4 | _aROC Curve |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSurvival |
700 | 1 | _aZhong, Ming-Kang | |
700 | 1 | _aXu, Hong-Bin | |
700 | 1 | _aLi, Ling | |
773 | 0 |
_tDie Pharmazie _gvol. 68 _gno. 6 _gp. 459-64 |
|
999 |
_c22937194 _d22937194 |